نتایج جستجو برای: xr type t film

تعداد نتایج: 2014743  

2012
Nianwen Shi Emily Durden Amelito Torres Zhun Cao Michael Happich

Background. Knowledge about real-world use of duloxetine and venlafaxine XR to treat depression in the UK is limited. Aims. To identify predictors of duloxetine or venlafaxine XR initiation. Method. Adult depressed patients who initiated duloxetine or venlafaxine XR between January 1, 2006 and September 30, 2007 were identified in the UK's General Practice Research Database. Demographic and cli...

Journal: :Medical physics 2012
T Giaddui Y Cui Z Yegingil J Xie W Chen J Galvin Y Yu Y Xiao

PURPOSE To study the effect of different filters on the dose response curves of the Gafchromic XRQA2 film. To measure the kV XVI cone-beam CT (CBCT) surface dose received during 3D and 4D imaging protocols in three body regions (head and neck, chest and pelvis). METHODS GafChromic XR- QA2 film (International Specialty Products, Wayne, NJ) dose response curves were generated for three irradiat...

2013
Julien Leblay

Since the beginning of the Semantic Web, RDF and SPARQL have become the standard data model and query language to describe resources on the Web. Large amounts of RDF data are now available either as stand-alone datasets or as metadata over semistructured documents, typically XML. The ability to apply RDF annotations over XML data emphasizes the need to represent and query data and metadata simu...

Journal: :HMD. Praxis der Wirtschaftsinformatik 2023

Zusammenfassung Extended-Reality-Technologien (XR-Technologien) haben in den vergangenen Jahren einen erheblichen technologischen Fortschritt erfahren. In der Arbeitswelt wird ihre Implementierung mit zahlreichen Vorteilen, wie z. B. Produktivitätssteigerungen, geringeren Kosten und verbessertem Lernen assoziiert. Dennoch stellt die disruptive XR-Technologie Unternehmen bei vor zahlreiche Herau...

2012
Jean Endicott Henrik Svedsäter Julie C Locklear

BACKGROUND We evaluated the effects of once-daily extended-release quetiapine fumarate (quetiapine XR) on patient-reported outcomes in generalized anxiety disorder (GAD). METHODS This is a report of a pooled analysis from three acute 8-week, randomized, placebocontrolled, fixed-dose (50, 150, 300 mg/day) studies and a 52-week maintenance flexible dose (50-300 mg/day) study of quetiapine XR mo...

2011
Joseph Peuskens

Effective management of schizophrenia remains a significant clinical challenge. While antipsychotic medications have proven efficacy in this disease, there remains an opportunity to further improve symptom control and long-term relapse prevention. Also, a number of factors, including tolerability and complex dosing regimens, can result in nonadherence to medication. Quetiapine is an atypical an...

2008
Ching-Yen Chien Sheng-Chieh Huang Shih-Hsiang Lin Yu-Chieh Huang Yi-Cheng Chen Lei-Chun Chou Tzu-Der Chuang Yu-Wei Chang Chia-Ho Pan Liang-Gee Chen

Table I. The different tiles for the benchmark image Q = 5 No tiles 8x8 4x4 1x32 1x1 Lena 344 K 346 K 350 K 345 K 433 K Baboon 484 K 490 K 504 K 497 K 704 K Airplane 274 K 276 K 279 K 279 K 332 K Pepper 387 K 390 K 397 K 392 K 501 K Q = 70 No tiles 8x8 4x4 1x32 1x1 Lena 8.34 K 9.55 K 12.6 K 10.9 K 38.9 K Baboon 31.8 K 32.8 K 35.7 K 34.3 K 60.7 K Airplane 9.27 K 10.5 K 13.8 K 12.3 K 39.6 K Peppe...

Journal: :Archives of physical medicine and rehabilitation 2015
J Scott Richards Charles H Bombardier Catherine S Wilson Anthony E Chiodo Larry Brooks Denise G Tate Nancy R Temkin Jason K Barber Allen W Heinemann Cheryl McCullumsmith Jesse R Fann

OBJECTIVES To (1) determine the efficacy of venlafaxine XR for the treatment of pain (secondary aim) in individuals with spinal cord injury (SCI) enrolled in a randomized controlled trial (RCT) on the efficacy of venlafaxine XR for major depressive disorder (MDD) (primary aim); and (2) test the hypothesis that venlafaxine XR would be effective for both neuropathic and nociceptive pain. DESIGN...

1994
A. Zapletal M. Karowski

The weights are computed for the Bethe vectors of an RSOS type model with periodic boundary conditions obeying Uq[sl(n)] (q = exp(iπ/r)) invariance. They are shown to be highest weight vectors. The q-dimensions of the corresponding irreducible representations are obtained. In the last years considerable progress has been made on the ”quantum symmetry” of integrable quantum chain models as the X...

1998
L. A. BREYER

Consider a Markov process X with finite lifetime ζ. In this paper, we derive sufficient conditions which allow the conditioning of X to an infinite lifetime. This is accomplished by showing the weak convergence, as s → ∞, of the laws of (Xr : r ≤ t | ζ > s).

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید